Literature DB >> 15666395

Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center.

Virginie Fouquet1, Arnaud Alves, Sophie Branchereau, Sophie Grabar, Dominique Debray, Emmanuel Jacquemin, Denis Devictor, Philippe Durand, Catherine Baujard, Monique Fabre, Danielle Pariente, Christophe Chardot, Bertrand Dousset, Pierre-Philippe Massault, Denis Bernard, Didier Houssin, Olivier Bernard, Frédéric Gauthier, Olivier Soubrane.   

Abstract

The aim of this study was to review our experience in orthotopic liver transplantation (OLT) for biliary atresia (BA) in children and analyze the survival and prognostic factors, and long-term outcome. We reviewed 332 OLTs performed in 280 children between the years 1986 and 2000. Univariate and multivariate analysis were performed on patient and graft survivals according to recipients' and donors' characteristics as well as intraoperative data. The long-term outcome among the 80 children living at 10 years after OLT was studied according to growth, immunosuppressive therapy, and liver and renal functions. Liver graft status was eventually documented by liver biopsy. Status of rehabilitation was assessed by reviewing school performance and employment. Overall patient survival rates at 1, 5, and 10 years were 85, 82, and 82%, respectively, and the corresponding overall graft survival rates were 77, 73, and 71%. In the multivariate analysis, we identified 4 independent prognostic factors: polysplenia syndrome (P = .03), United Network for Organ Sharing (UNOS) status (P = .05), donor's age (P = .01), and perioperative surgical complications (P = .03). At 10 years after transplant, 80 children were alive and had normal growth rates. Liver histology was abnormal in 73% of these long-term survivors, mainly due to chronic rejection and centrilobular fibrosis. A total of 63 of the 80 children attended normal school and in 55 children (69%) school performance was not delayed. In conclusion, we discovered that a good long-term survival could be achieved after liver transplantation for BA, with a 82% survival rate at 10 years with normal scholastic studies in the majority of recipients.

Entities:  

Mesh:

Year:  2005        PMID: 15666395     DOI: 10.1002/lt.20358

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  24 in total

1.  Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.

Authors:  A C Kalil; J Mattei; D F Florescu; J Sun; R S Kalil
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  What determines ageing of the transplanted liver?

Authors:  Russell Hodgson; Chris Christophi
Journal:  HPB (Oxford)       Date:  2014-09-28       Impact factor: 3.647

3.  Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Authors:  Wei-Wei Li; Yan Yang; Qi-Gang Dai; Li-Li Lin; Tong Xie; Li-Li He; Jia-Lei Tao; Jin-Jun Shan; Shou-Chuan Wang
Journal:  Metabolomics       Date:  2018-06-21       Impact factor: 4.290

4.  Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation.

Authors:  Yukihiro Sanada; Koshi Matsumoto; Taizen Urahashi; Yoshiyuki Ihara; Taiichi Wakiya; Noriki Okada; Naoya Yamada; Yuta Hirata; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

5.  Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases.

Authors:  Robert S Venick; Douglas G Farmer; Sue V McDiarmid; John P Duffy; Sherilyn A Gordon; Hasan Yersiz; Johnny C Hong; Jorge H Vargas; Marvin E Ament; Ronald W Busuttil
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

Review 6.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  [Predictive parameters in children with biliary atresia].

Authors:  J Leonhardt; J F Kuebler; C Turowski; R von Wasielewski; E D Pfister; T Becker; B M Ure; C Petersen
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

8.  Liver transplantation for biliary atresia: A single-center study from mainland China.

Authors:  Qi-Gen Li; Ping Wan; Jian-Jun Zhang; Qi-Min Chen; Xiao-Song Chen; Long-Zhi Han; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

9.  Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.

Authors:  Adam S Arterbery; Awo Osafo-Addo; Yaron Avitzur; Maria Ciarleglio; Yanhong Deng; Steven J Lobritto; Mercedes Martinez; David A Hafler; Markus Kleinewietfeld; Udeme D Ekong
Journal:  J Immunol       Date:  2016-04-18       Impact factor: 5.422

10.  Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications.

Authors:  Yukiko Takahashi; Yuko Nishimoto; Toshiharu Matsuura; Makoto Hayashida; Tatsuro Tajiri; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.